Taysha Gene Therapies (TSHA) PT Raised to $14 at BMO Capital on Differentiation
Tweet Send to a Friend
(Updated - June 23, 2026 8:46 AM EDT)
BMO Capital analyst Evan Seigerman raised the price target on Taysha ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BMO Capital analyst Evan Seigerman raised the price target on Taysha ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
